17 alpha-hydroxyprogesterone caproate has been researched along with mifepristone in 2 studies
Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (mifepristone) | Trials (mifepristone) | Recent Studies (post-2010) (mifepristone) |
---|---|---|---|---|---|
517 | 88 | 251 | 6,536 | 595 | 1,758 |
Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | mifepristone (IC50) |
---|---|---|---|
Glucocorticoid receptor | Canis lupus familiaris (dog) | 0.0264 | |
Bile salt export pump | Homo sapiens (human) | 2.02 | |
Estrogen receptor | Homo sapiens (human) | 4.311 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.0249 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.0003 | |
Progesterone receptor | Homo sapiens (human) | 0.1347 | |
Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.774 | |
Glucocorticoid receptor | Mus musculus (house mouse) | 0.0022 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0022 | |
Mineralocorticoid receptor | Homo sapiens (human) | 2.0938 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 9.5 | |
Coagulation factor VII | Homo sapiens (human) | 0.0003 | |
Androgen receptor | Homo sapiens (human) | 0.2988 | |
Cytochrome P450 2C8 | Homo sapiens (human) | 1.5 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 4.9 | |
Steroid 17-alpha-hydroxylase/17,20 lyase | Rattus norvegicus (Norway rat) | 0.0016 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.555 | |
Tissue factor | Homo sapiens (human) | 0.0003 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.0083 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0014 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0022 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0022 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0078 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0022 | |
Substance-P receptor | Cavia porcellus (domestic guinea pig) | 0.0015 | |
Mu-type opioid receptor | Homo sapiens (human) | 2.457 | |
Estrogen receptor beta | Homo sapiens (human) | 1.528 | |
Glucocorticoid receptor | Sus scrofa (pig) | 0.0153 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and mifepristone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and mifepristone
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |